Latest Drug Approvals news
Alecensa Approved as First and Only ALK Inhibitor for Non-Small Cell Lung Cancer
posted April 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Adds Fasenra Indication for Severe Asthma in Children
posted April 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Abecma for Relapsed, Refractory Multiple Myeloma
posted April 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
AACR: Little Benefit Seen for Cancer Drugs Given Accelerated Approval
posted April 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Obesity Linked to Early-Onset Cancer Risk in Young Adults 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
